About Advion
Advion is a company based in Ithaca (United States) founded in 1993 was acquired by Quintiles in February 2012. Advion has raised $45.64 million across 8 funding rounds from investors including Skyline Ventures, Polaris Partners and IQVIA. Advion has completed 1 acquisition, including Interchim. Advion offers products and services including ex press ion CMS, AVANT HPLC, and SOLATION ICP-MS. Advion operates in a competitive market with competitors including 908 Devices, BioAgilytix, Refeyn, Alderley Analytical and Tentamus, among others.
- Headquarter Ithaca, United States
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Advion, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$45.64 M (USD)
in 8 rounds
-
Latest Funding Round
$1.5 M (USD), Series D
Jun 25, 2014
-
Investors
Skyline Ventures
& 2 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Quintiles
(Feb 01, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Advion
Advion offers a comprehensive portfolio of products and services, including ex press ion CMS, AVANT HPLC, and SOLATION ICP-MS.
Compact mass spectrometer for real-time chemical analysis in labs.
High-performance liquid chromatography system for compound separation.
ICP-MS solution for multi-element detection in scientific testing.
People of Advion
Unlock access to complete
Funding Insights of Advion
Advion has successfully raised a total of $45.64M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $1.5 million completed in June 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Advion
Advion has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Skyline Ventures, Polaris Partners and IQVIA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US life sciences companies are invested in by Skyline Ventures.
|
Locked | Locked | Locked | |
|
US focused venture capital firm
|
Locked | Locked | Locked | |
|
Healthcare advancements are driven by IQVIA through connected intelligence.
|
Locked | Locked | Locked |
Investor details for Advion
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Advion
Advion has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Interchim.
Investment portfolio details for Advion
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer of consumables and instruments for research and industry.
|
Locked | Locked | 1970 | Locked |
Complete acquisition details for Advion
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Advion
Detailed financials for Advion
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Advion Comparisons
Peer comparison for Advion
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Advion
Advion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 908 Devices, BioAgilytix, Refeyn, Alderley Analytical and Tentamus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Handheld chemical detection devices are manufactured using mass spectrometry.
|
|
| Locked | Locked | Locked |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| Locked | Locked | Locked |
Single molecular mass measurement technology is developed for biomolecules.
|
|
| Locked | Locked | Locked |
Bioanalytical assays for drug development are developed and validated.
|
|
| Locked | Locked | Locked |
Analytical and quality assurance services are provided for diverse industries.
|
|
| Locked | Locked | Locked |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
Detailed competitors of Advion
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Advion
Complete news archive for Advion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Advion
Advion was founded in 1993 and raised its 1st funding round 9 years after it was founded.
Advion is headquartered in Ithaca, United States. It is registered at Ithaca, New York, United States.
Advion is a funded company, having raised a total of $45.64M across 8 funding rounds to date.
Advion Biosciences, a spin-off from the Cornell University, is engaged in the development and manufacture of innovative products based on microfluidics and mass spectrometry for life science research and clinical development. The companys proprietary products are expression CMS (Compact Mass Spectrometer), Chip-Mate (a nano-LC ion source), NanoTek(microfluidics flow-chemistry system used for probe synthesis for imaging), Triversa NanoMate(Chip-based electrospray ionization). These products have applications such as reaction monitoring, protein assays, biomarkers and peptide synthesis, PET chemistry, lipid analysis and metabolite identification, radiopharmaceutical research and production. The company has sales and support offices in North America, Europe, and Japan. Advion Bioservices bioanalytical services division was sold off to Quintiles in 2011.
Advion's top competitors include 908 Devices, Alderley Analytical and BioAgilytix.
Advion offers ex press ion CMS, AVANT HPLC, and SOLATION ICP-MS.
Advion has made 1 acquisition, including Interchim.
Advion has 3 investors. Key investors include Skyline Ventures, Polaris Partners, and IQVIA.